InvestorsHub Logo
icon url

TheDane

07/20/20 8:35 AM

#312965 RE: Hugon #312960

Besides clout, money (redundant?) and name recognition, what does Remdesivir have that BrilAcidin doesn’t already have? It wasn’t an approved drug but presumably had been tested in humans. Was it in a phase 3 trial?